Back
Top 53%
11.7%
Top 4%
6.4%
Top 26%
6.4%
Top 16%
6.4%
Top 2%
6.4%
Top 56%
5.0%
Top 2%
5.0%
Top 2%
5.0%
Top 0.7%
4.1%
Top 0.7%
1.9%
Top 3%
1.9%
#1
1.9%
Top 22%
1.9%
Top 0.6%
1.9%
Top 3%
1.9%
Top 0.8%
1.5%
Top 3%
1.3%
Top 13%
1.2%
Top 11%
1.0%
Top 13%
0.7%
Top 23%
0.7%
Top 6%
0.7%
Top 9%
0.7%
Top 3%
0.7%
Landscape assessment to characterize baseline access and multilevel barriers to IMProve Access to CAR-T CD19 therapy (IMPACT study) across Europe.
2025-11-06
oncology
Title + abstract only
View on medRxiv
Show abstract
Background/PurposeChimeric Antigen Receptor-T Cell Therapy (CAR-T) has revolutionized the treatment of B-cell precursor acute lymphoblastic leukemia (B-ALL), but its global availability is limited. This study assessed current access and barriers to CAR-T CD19 cell therapy for children across Europe. MethodsA country questionnaire developed by the EBMT PDWP, St. Jude Childrens Research Hospital, and IBFM assessed current access to advanced therapies for B-ALL in Europe using Qualtrics software. ...
Predicted journal destinations
1
PLOS ONE
1737 training papers
2
Cancers
57 training papers
3
BMJ Open
553 training papers
4
Nature Communications
483 training papers
5
Frontiers in Oncology
34 training papers
6
Scientific Reports
701 training papers
7
Clinical Cancer Research
22 training papers
8
JAMA Network Open
125 training papers
9
Cancer Medicine
17 training papers
10
Blood Advances
16 training papers
11
British Journal of Cancer
22 training papers
12
JAMA
17 training papers
13
eLife
262 training papers
14
Journal of Allergy and Clinical Immunology
15 training papers
15
BMC Cancer
21 training papers
16
Clinical Pharmacology & Therapeutics
19 training papers
17
Journal of Clinical Investigation
50 training papers
18
Proceedings of the National Academy of Sciences
100 training papers
19
Frontiers in Immunology
140 training papers
20
iScience
74 training papers
21
PLOS Medicine
95 training papers
22
Diagnostics
36 training papers
23
PeerJ
46 training papers
24
Cell Reports
25 training papers